Agency
Cumberland County Health Dept
Cumberland County Health Dept was paid $11.08M by Medicaid between Jan 2018 and Dec 2024, across 94 billing codes. Its largest line is 99199, Unlisted special service, procedure or report — 80% of everything it billed.
33Billing provider infoCUMBERLAND COUNTY HEALTH DEPT
FAYETTEVILLE, NC 28301
FAYETTEVILLE, NC 28301
33aNPI1831249986assigned 01/11/2007
33bProvider typeCase Management Agency
28Total paid$11.08M
24GClaims1,909,084
24DCodes billed94
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Case Management Agency providers in North Carolina
Rank by total paid#26 of 195
Median peer was paid$2.05M
This provider vs. median5.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,925 | $270K | |
| 2019 | 16,901 | $331K | |
| 2020 | 11,342 | $280K | |
| 2021 | 231,728 | $1.55M | |
| 2022 | 491,994 | $2.81M | |
| 2023 | 534,200 | $2.70M | |
| 2024incomplete | 606,994 | $3.14M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99199 | Unlisted special service, procedure or report | 80% | 1,794,580 | 1,732,313 | $8.86M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.6% | 3,918 | 3,168 | $398K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.0% | 16,973 | 13,905 | $218K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.8% | 9,092 | 7,536 | $201K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.6% | 2,543 | 2,163 | $179K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 5,304 | 4,181 | $147K |
| T1002 | Rn services, up to 15 minutes | 1.2% | 3,325 | 2,397 | $135K |
| 90716 | <1% | 1,427 | 1,227 | $68K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 526 | 452 | $62K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,264 | 1,957 | $59K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,265 | 1,956 | $55K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 958 | 840 | $46K |
82 more codes
| 99401 | <1% | 2,031 | $41K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 380 | $41K |
| 0001A | <1% | 712 | $36K | |
| 87210 | <1% | 7,542 | $33K | |
| 81025 | <1% | 4,492 | $32K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,219 | $31K |
| 0002A | <1% | 583 | $30K | |
| 90715 | <1% | 3,636 | $29K | |
| 90734 | <1% | 4,676 | $23K | |
| 96127 | <1% | 4,171 | $23K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,040 | $20K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 993 | $20K |
| 90707 | <1% | 864 | $20K | |
| 99501 | <1% | 376 | $18K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 106 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 420 | $16K |
| 0012A | <1% | 321 | $14K | |
| 99502 | <1% | 244 | $14K | |
| S0280 | Medical home program, comprehensive care coordination and planning, initial plan | <1% | 387 | $14K |
| 99385 | <1% | 95 | $13K | |
| 90686 | <1% | 3,298 | $13K | |
| 0011A | <1% | 353 | $13K | |
| 90649 | <1% | 749 | $11K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 121 | $11K |
| 99383 | <1% | 127 | $10K | |
| 90620 | <1% | 451 | $9K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,870 | $9K |
| 90746 | <1% | 173 | $8K | |
| 85027 | <1% | 1,101 | $8K | |
| 90651 | <1% | 576 | $7K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 710 | $7K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 382 | $7K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 69 | $6K |
| 90480 | <1% | 200 | $6K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 57 | $5K |
| 0003A | <1% | 70 | $4K | |
| 0031A | <1% | 60 | $3K | |
| 96160 | <1% | 562 | $2K | |
| 90474 | <1% | 144 | $2K | |
| 91320 | <1% | 72 | $2K | |
| 0072A | <1% | 28 | $1K | |
| 99384 | <1% | 13 | $1K | |
| 0013A | <1% | 23 | $1K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 13 | $1K |
| 80061 | Lipid panel | <1% | 78 | $1K |
| 90656 | <1% | 155 | $1K | |
| 90670 | <1% | 1,291 | $1K | |
| 90714 | <1% | 65 | $1K | |
| 90710 | <1% | 973 | $1K | |
| 90633 | <1% | 1,412 | $1K | |
| 0064A | <1% | 17 | $951.00 | |
| 96161 | <1% | 289 | $946.22 | |
| 99442 | <1% | 20 | $805.00 | |
| 0124A | <1% | 32 | $780.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 79 | $778.96 |
| 86701 | <1% | 90 | $735.00 | |
| 90713 | <1% | 212 | $709.02 | |
| 86592 | <1% | 101 | $478.20 | |
| 90744 | <1% | 649 | $229.70 | |
| 90677 | <1% | 52 | $67.46 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 15 | $61.70 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 184 | $58.25 |
| 81003 | <1% | 14 | $37.49 | |
| 94760 | <1% | 19 | $10.65 | |
| 91312 | <1% | 32 | $9.56 | |
| 90700 | 0% | 339 | $0.00 | |
| 91300 | 0% | 1,464 | $0.00 | |
| 90687 | 0% | 112 | $0.00 | |
| 99173 | 0% | 16 | $0.00 | |
| 90685 | 0% | 56 | $0.00 | |
| 90696 | 0% | 453 | $0.00 | |
| 91301 | 0% | 725 | $0.00 | |
| 90698 | 0% | 541 | $0.00 | |
| 90680 | 0% | 155 | $0.00 | |
| 99000 | 0% | 27 | $0.00 | |
| 90619 | 0% | 488 | $0.00 | |
| 90647 | 0% | 45 | $0.00 | |
| 91307 | 0% | 68 | $0.00 | |
| 91303 | 0% | 69 | $0.00 | |
| 92587 | 0% | 16 | $0.00 | |
| 91309 | 0% | 19 | $0.00 | |
| 90723 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAY, TINA (BILLING SUPERVISOR)
Parent organizationCOUNTY OF CUMBERLAND